Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC-PC)

Clinical trial NCT04615845 · TERMINATED

Trial details

NCT number: NCT04615845
Sponsor: Pharmicell Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Castration Resistant Prostate Cancer, CRPC

Start date: 2021-06-21
Primary completion: 2022-02-15
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.